Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injection Manufacturing: SOP for Documentation of Packaging Line Performance – V 2.0

Posted on By

Sterile Injection Manufacturing: SOP for Documentation of Packaging Line Performance – V 2.0

Standard Operating Procedure for Documentation of Packaging Line Performance


Department Sterile Injection Manufacturing
SOP No. SOP/SIM/199/2025
Supersedes SOP/SIM/199/2022
Page No. Page 1 of 13
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

This SOP defines the standard process for documentation of packaging line performance in the Sterile Injection Manufacturing department. It ensures compliance with GMP, supports traceability of operations, and aids in evaluating efficiency and identifying areas of improvement.

2. Scope

This procedure applies to all

sterile injectable packaging lines, including vial packing, ampoule packing, prefilled syringe lines, and automated or semi-automated systems operated at the facility.

3. Responsibilities

  • Packaging Operator: Records line parameters and output in real time.
  • Line Supervisor: Reviews and verifies records and ensures any deviations are reported immediately.
  • QA Executive: Audits documentation, verifies compliance, and reviews trends for continuous improvement.

4. Accountability

The Head of Production and Head of Quality Assurance are accountable for ensuring the documentation process is implemented and followed as per this SOP.

See also  Sterile Injectable Manufacturing: SOP for Optimization of Injection Viscosity - V 2.0

5. Procedure

5.1 Initiation of Packaging Activity

  1. Prior to line startup, ensure that line clearance has been completed and documented as per SOP/SIM/191/2025.
  2. Verify availability of approved batch packaging record (BPR) and approved labels.
  3. Start the packaging line under supervision, recording the start time and initial observations.

5.2 Real-Time Recording of Performance Parameters

  1. Use the Packaging Line Performance Log (Annexure-1) to record the following:
    • Line Start and Stop Times
    • Shifts and Operator Names
    • Machine Speeds and Output per Hour
    • Downtime (with reasons)
    • Rejected Units (categorized by cause)
  2. Ensure all entries are made in real-time using indelible ink. Do not leave blank spaces.

5.3 Shift Handover Documentation

  1. At the end of each shift, the outgoing operator must brief the incoming operator and sign the handover section in the logbook.
  2. Any unresolved issues must be clearly documented and highlighted to the supervisor.
See also  Sterile Injectable Manufacturing: SOP for Cross-Verification of In-Process Data - V 2.0

5.4 Recording Deviations and Incidents

  1. Any deviations from standard packaging line operations (e.g., frequent rejections, unplanned stoppages) must be recorded in the deviation section of the logbook.
  2. QA must be notified immediately for evaluation and impact assessment.
  3. Complete a Deviation Form (Annexure-2) if applicable.

5.5 Verification of Line Performance

  1. Line Supervisor shall verify the log entries every 4 hours and sign-off on completed pages.
  2. QA Executive shall conduct end-of-day review to confirm that data is complete, legible, and compliant.

5.6 Compilation and Archiving

  1. At batch completion, line performance data shall be compiled and attached to the BPR.
  2. All original logbooks must be retained in QA archives for a minimum of 5 years.

5.7 Training and Review

  1. All packaging line personnel shall be trained on this SOP annually.
  2. Training records to be maintained as per Annexure-3.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • BPR: Batch Packaging Record
  • QA: Quality Assurance
  • GMP: Good Manufacturing Practice

7. Documents

  1. Packaging Line Performance Log – Annexure-1
  2. Deviation Reporting Form – Annexure-2
  3. Training Attendance Record – Annexure-3
See also  Quality Control: SOP for Analyzing Residual Solvents in Injectable Formulations - V 2.0

8. References

  • WHO TRS 986 Annex 2 – GMP for Pharmaceutical Products
  • EU GMP Annex 15 – Qualification and Validation
  • 21 CFR Part 211 – Current Good Manufacturing Practice

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Packaging Line Performance Log

Date Shift Operator Output (Units) Downtime (min) Remarks
24/06/2025 Morning Rajesh Kumar 10,000 30 Label roll jammed

Annexure-2: Deviation Reporting Form

Date Batch No. Description of Deviation Immediate Action Taken QA Comments
24/06/2025 BATCH2025A12 Unexpected stoppage due to sensor failure Sensor replaced No impact on product

Annexure-3: Training Attendance Record

Employee Name Designation Training Date Trainer Signature
Sunita Reddy Packing Operator 22/06/2025 QA Executive

Revision History:

Revision Date Revision No. Revision Details Reason Approved By
01/03/2022 1.0 Initial Release New SOP QA Head
24/06/2025 2.0 Updated log structure and review frequency Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Biosimilars: SOP for Inline UV Absorbance Monitoring – V 2.0
Next Post: Gel Manufacturing: SOP for Production of Thermosensitive Gels – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version